IBJNews

Lilly's fourth-quarter profit surges, topping analysts' predictions

Back to TopCommentsE-mailPrintBookmark and Share

Profit at Eli Lilly and Co. surged 28 percent in the fourth quarter, edging above analysts’ expectations.

The Indianapolis-based drugmaker earned $1.2 billion in the three months ended Dec. 31, compared with $915 million in the same quarter a year ago.

Earnings per share totaled $1.05 for the quarter, compared with 91 cents a year ago. Excluding restructuring costs from Lilly’s ongoing layoffs, the company would have earned $1.11 per share in the most recent quarter.

On that basis, Wall Street analysts were expecting profit of $1.10 per share, according to a survey by Thomson Reuters.

Lilly’s revenue rose 4 percent in the quarter to $6.2 billion, also exceeding analysts’ predictions. Sales grew mainly from increased demand for Lilly’s drugs in foreign markets and because of increased prices in the United States.

“These results allowed us to deliver attractive earnings growth and a healthy dividend for our shareholders, while still investing in the research and development and business development activities that will enable us to bring the next generation of new medicines to patients," said Lilly CEO John Lechleiter, in a statement.

For all of 2010, Lilly’s revenue grew 6 percent to $23.1 billion and its profit rose 17 percent to $5.1 billion. Profit per share was $4.58.

But for 2011, Lilly predicts its profit will drop by about 10 percent, to a range of $3.92 to $4.07 per share. Lilly’s bestselling drug, Zyprexa, will face generic competition in the United States and Europe beginning in November. And already, another Lilly’s blockbuster, Gemzar, is losing sales to cheaper generic copies.

Gemzar sales fell 22 percent in the fourth quarter. Lilly’s best sales growth came from Cymbalta, which grew 19 percent in the quarter.

ADVERTISEMENT

  • MIDDLE MAN
    It is almost has if Lilly has transformed itself into a company that doesn't necessarily make complex molecules, but brokers and markets them. Very clever. Good Lord knows we need Lilly for Indy to grow.

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT